Filing Details
- Accession Number:
- 0001567619-21-017761
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-10-01 17:37:17
- Reporting Period:
- 2021-09-30
- Accepted Time:
- 2021-10-01 17:37:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1704292 | Zai Lab Ltd | ZLAB | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1644888 | Tao Fu | C/O Zai Lab Limited 4560 Jinke Road, Bldg 1, 4Th Floor Pudong, Shanghai F4 201210 | President & Coo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2021-09-30 | 2,714 | $105.55 | 104,786 | No | 4 | S | Indirect | See footnote |
| Ordinary Shares | Disposition | 2021-09-30 | 4,619 | $106.73 | 100,167 | No | 4 | S | Indirect | See footnote |
| Ordinary Shares | Disposition | 2021-09-30 | 2,417 | $107.85 | 97,750 | No | 4 | S | Indirect | See footnote |
| Ordinary Shares | Disposition | 2021-09-30 | 250 | $108.85 | 97,500 | No | 4 | S | Indirect | See footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Ordinary Shares | 187,668 | Direct |
Footnotes
- The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person's spouse, dated June 17, 2021, expires February 28, 2022 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
- Reflects a weighted average sale price of $105.55 per share, at prices ranging from $105.20 to $106.20 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Reflects a weighted average sale price of $106.73 per share, at prices ranging from $106.30 to $107.21 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Reflects a weighted average sale price of $107.85 per share, at prices ranging from $107.45 to $108.30 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Reflects a weighted average sale price of $108.85 per share, at prices ranging from $108.55 to $108.93 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Shares held by Reporting Person's spouse.
Billionaire Hedge Funds
